Ancillary Regulations : Part IV 2, Part IV OJ 2000, 369

Part IV OJ 2000, 369: Notice dated 31 May 2000 concerning new versions of various forms

E / D / F

Table of Contents

Foreword

Ancillary Regulations

Part IV

Part IV 2

Part IV OJ 2000, 369: Notice dated 31 May 2000 concerning new versions of various forms

Part IV OJ 1998, 597: Notice dated 20 November 1998 concerning new versions of various forms

Part IV OJ 2005, 366: Notice from the European Patent Office dated 23 May 2005 concerning the July 2005 update of the Request for Grant form (Form 1001)

Part IV - OJ 2000, 369

Notice dated 31 May 2000 concerning new versions of various forms

- OJ 2000, 369 -

1. Most EPO application forms have been revised of late. The latest versions are reproduced below in the following order¹:

-	Designation of inventor (EPA/EPO/OEB Form 1002 02.00),

-	Authorisation (EPA/EPO/OEB Form 1003 02.00),

-	Receipt for documents (relating to international applications) (EPA/EPO/OEB Form 1031 01.99),

-	Acknowledgement of receipt for subsequently filed items (EPA/EPO/OEB Form 1037 03.99),

-	Letter accompanying subsequently filed items (EPA/EPO/OEB Form 1038 04.00).

2. The current versions of the forms Request for grant (EPA/EPO/OEB Form 1001 07.99) and Entry into the European phase (EPA/EPO/OEB Form 1200 03.00) and relevant notes were published at the time of last revision². In addition the Notes relating to the version of Form 1200 04.99³ that may be used for a transitional period were revised and reprinted under reference 03.00; they are not reproduced here.

3. The use of revised forms is recommended.

4. The forms are obtainable free of charge from the EPO (preferably in Vienna, but also Munich, The Hague and Berlin) and the central industrial property offices of the contracting states.

5.The forms can also be downloaded from the EPO's website (http://www.european-patent-office.org)⁴ in pdf and Word 97 formats.

______________________

¹	See point 6 of the Notice dated 20 November 1998, OJ EPO 1998, 597.

²	OJ EPO 1999, 359, and 2000, 65.

³	OJ EPO 2000, 65, point 2.

⁴	OJ EPO 1997, 575.